|
GOLGA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.920420E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.281700E-02 |
| Normal-vs-Stage2 |
1.523990E-01 |
| Normal-vs-Stage3 |
1.702470E-02 |
| Normal-vs-Stage4 |
4.027800E-02 |
| Stage1-vs-Stage2 |
8.493200E-01 |
| Stage1-vs-Stage3 |
5.656400E-01 |
| Stage1-vs-Stage4 |
7.809800E-01 |
| Stage2-vs-Stage3 |
5.833600E-01 |
| Stage2-vs-Stage4 |
7.146800E-01 |
| Stage3-vs-Stage4 |
8.783800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.215900E-02 |
| Normal-vs-AfricanAmerican |
9.266000E-01 |
| Normal-vs-Asian |
1.405640E-01 |
| Caucasian-vs-AfricanAmerican |
1.061640E-01 |
| Caucasian-vs-Asian |
7.405200E-01 |
| AfricanAmerican-vs-Asian |
1.868000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.553730E-02 |
| Normal-vs-Female |
3.021600E-02 |
| Male-vs-Female |
5.972200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.131900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.973800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.938100E-03 |
| Normal-vs-Age(81-100Yrs) |
5.867000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.354000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.551630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.930400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.669800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.301000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.997800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.803200E-01 |
| Classical-VS-Follicular |
2.567700E-04 |
| Classical-VS-Other |
8.998500E-02 |
| Classical-VS-Normal |
1.865620E-01 |
| Tall-VS-Follicular |
2.570200E-01 |
| Tall-VS-Other |
3.711200E-01 |
| Tall-VS-Normal |
5.240400E-02 |
| Follicular-VS-Other |
8.495000E-01 |
| Follicular-VS-Normal |
3.791400E-04 |
| Other-VS-Normal |
3.628400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.880400E-03 |
| Normal-vs-N1 |
5.122100E-03 |
| N0-vs-N1 |
5.091600E-01 |
|
|
